Lisdexamfetamine dimesylate has a typical plasma elimination half-life of less than an hour on average
Ozempic (semaglutide) received FDA approval exclusively for glycemic control in type 2 diabetes, and most major insurers restrict reimbursement to that indication alone
Patients With Class II Obesity and Serious Comorbidities These include: Type 2 diabetes mellitus Obstructive sleep apnea Hypertension Dyslipidemia Non-alcoholic fatty liver disease Michigan Medicaids updated clinical guidelines mirror the states existing requirements for bariatric surgery coverage, which similarly use BMI thresholds and comorbidities as qualifying criteria (MDHHS, 2023)
This portability enhances the ease treatment and research regimens, as subjects can conveniently carry their pens and administer peptides without disrupting daily activities
Medical weight loss uses a clinical approach, including diagnostic testing and prescription treatments like GLP-1s, to address the biological factors of weight gain
Advise them to speak with their GP